These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36167351)

  • 1. Therapeutic Response of Multifunctional Lipid and Micelle Formulation in Hepatocellular Carcinoma.
    Wu J; Wang F; Dong J; Zhang S; Li N; Zhao H; Liu X; Gao Z; Zhang B; Tian G
    ACS Appl Mater Interfaces; 2022 Oct; 14(40):45110-45123. PubMed ID: 36167351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axis.
    Li Z; Wang F; Li Y; Wang X; Lu Q; Wang D; Qi C; Li C; Li Z; Lian B; Tian G; Gao Z; Zhang B; Wu J
    Biomaterials; 2021 Sep; 276():121003. PubMed ID: 34273686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma.
    Li Y; Wu J; Lu Q; Liu X; Wen J; Qi X; Liu J; Lian B; Zhang B; Sun H; Tian G
    Int J Nanomedicine; 2022; 17():2559-2575. PubMed ID: 35698562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial-mesenchymal transition reversion.
    Guo J; Zeng H; Shi X; Han T; Liu Y; Liu Y; Liu C; Qu D; Chen Y
    J Nanobiotechnology; 2022 Mar; 20(1):114. PubMed ID: 35248071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Delivery of Curcumin and Capsaicin by Dual-Targeting Liposomes for Inhibition of aHSC-Induced Drug Resistance and Metastasis.
    Qi C; Wang D; Gong X; Zhou Q; Yue X; Li C; Li Z; Tian G; Zhang B; Wang Q; Wei X; Wu J
    ACS Appl Mater Interfaces; 2021 Apr; 13(14):16019-16035. PubMed ID: 33819006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient Sequential Co-Delivery Nanosystem for Inhibition of Tumor and Tumor-Associated Fibroblast-Induced Resistance and Metastasis.
    Li C; Wang Z; Zhang Y; Zhu Y; Xu M; Lei H; Zhang D
    Int J Nanomedicine; 2024; 19():1749-1766. PubMed ID: 38414527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy.
    Li Z; Liu C; Li C; Wang F; Liu J; Zheng Z; Wu J; Zhang B
    J Nanobiotechnology; 2021 Dec; 19(1):421. PubMed ID: 34906155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential Delivery of Quercetin and Paclitaxel for the Fibrotic Tumor Microenvironment Remodeling and Chemotherapy Potentiation via a Dual-Targeting Hybrid Micelle-in-Liposome System.
    Duan H; Liu C; Hou Y; Liu Y; Zhang Z; Zhao H; Xin X; Liu W; Zhang X; Chen L; Jin M; Gao Z; Huang W
    ACS Appl Mater Interfaces; 2022 Mar; 14(8):10102-10116. PubMed ID: 35175043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acidic tumor microenvironment-sensitive liposomes enhance colorectal cancer therapy by acting on both tumor cells and cancer-associated fibroblasts.
    Li C; Li Z; Gong X; Liu J; Zheng T; Wang F; Wu J; Zhang B
    Nanoscale; 2021 Jun; 13(23):10509-10525. PubMed ID: 34096957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pH‑responsive hyaluronic acid nano‑vehicle co‑encapsulating doxorubicin and all‑trans retinoic acid for the inhibition of hepatic stellate cell‑induced tumor growth and metastasis.
    Lu Q; Gong X; Jia G; Wu J; Liu S; Song K; Tian G
    Mol Med Rep; 2023 Aug; 28(2):. PubMed ID: 37326031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
    Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer-associated fibroblasts in hepatocellular carcinoma.
    Kubo N; Araki K; Kuwano H; Shirabe K
    World J Gastroenterol; 2016 Aug; 22(30):6841-50. PubMed ID: 27570421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin and berberine co-loaded liposomes for anti-hepatocellular carcinoma therapy by blocking the cross-talk between hepatic stellate cells and tumor cells.
    Wu J; Qi C; Wang H; Wang Q; Sun J; Dong J; Yu G; Gao Z; Zhang B; Tian G
    Front Pharmacol; 2022; 13():961788. PubMed ID: 36188590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer.
    Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L
    J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
    Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
    J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma.
    Khawar IA; Park JK; Jung ES; Lee MA; Chang S; Kuh HJ
    Neoplasia; 2018 Aug; 20(8):800-812. PubMed ID: 29981501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts induce immunotherapy resistance in hepatocellular carcinoma animal model.
    Yu L; Liu Q; Huo J; Wei F; Guo W
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):36-40. PubMed ID: 32415924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy.
    Wang X; Wu F; Li G; Zhang N; Song X; Zheng Y; Gong C; Han B; He G
    Acta Biomater; 2018 Jul; 74():414-429. PubMed ID: 29787814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α.
    Huang M; Fu M; Wang J; Xia C; Zhang H; Xiong Y; He J; Liu J; Liu B; Pan S; Liu F
    Biochem Pharmacol; 2021 Jun; 188():114527. PubMed ID: 33741330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated Fibroblasts induce epithelial-mesenchymal transition
    Jia C; Wang G; Wang T; Fu B; Zhang Y; Huang L; Deng Y; Chen G; Wu X; Chen J; Pan Y; Tai Y; Liang J; Li X; Hu K; Xie B; Li S; Yang Y; Chen G; Zhang Q; Liu W
    Int J Biol Sci; 2020; 16(14):2542-2558. PubMed ID: 32792856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.